Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Wellesley Pharmaceuticals Company Profile - aVenture Research

Wellesley Pharmaceuticals

Wellesley Pharmaceuticals

Wellesley Pharmaceuticals, based in Newtown, US, develops Paxerol, a solution for Nocturia.

: 30
: Private company

Newtown, PA, US🇺🇸United States

Wellesley Pharmaceuticals, founded in Newtown, US, is dedicated to addressing the medical condition of nocturia, which affects approximately 2.4 billion people worldwide. Their core mission is to improve the quality of life for individuals suffering from frequent nighttime urination. The company’s flagship product, Paxerol, is specifically designed to provide a solution for nocturia, aiming to reduce the number of nightly bathroom visits and enhance sleep quality.

Key figures associated with Wellesley Pharmaceuticals include its founders and notable investors who have supported the development of Paxerol. The company has achieved significant milestones in the pharmaceutical industry by bringing attention to nocturia and offering an effective treatment option. The impact of their work is reflected in the improved sleep and overall well-being of their users, positioning Wellesley Pharmaceuticals as a pivotal player in the healthcare sector focused on urinary health.

Similar Companies

Woolsey Pharmaceuticals

woolseypharma.com

Somnus Therapeutics

somnusthera.com

Welmedix Consumer Healthcare

welmedix.com

FemmePharma Global Healthcare

fpghc.com

Fervent Pharmaceuticals

ferventpharma.com

PellePharm

pellepharm.com

Wilmington Pharmaceuticals

Evestra

evestra.com

White Sands Pharma

Parnell Pharmaceuticals

parnellpharm.com

WavoDyne Therapeutics

AcelRx Pharmaceuticals

PleoPharma

pleopharma.com

Manhattan Pharmaceuticals

Aquestive Therapeutics

aquestive.com

Solace Pharmaceuticals

Perosphere

Petros Pharmaceuticals

petrospharma.com

PCTRx

Welsis

Quick Facts

When was Wellesley Pharmaceuticals' last funding round?

Wellesley Pharmaceuticals' most recent funding round was for $7M (USD) in January 2016.

How much disclosed funding has Wellesley Pharmaceuticals raised?

As of Jan 1, 2016, Wellesley Pharmaceuticals has disclosed funding of $7.9M (USD).

Classification

Ownership: Private
Technology: Biotech
Geographic Exposure: United States

Revenue

Recurring
Software

Customer

Consumers
Enterprise

Main Product

Pharmaceuticals

Tags: Healthtech

Also Known As: Wellesley Pharmaceuticals, LLC

Headquarters: 3 Valley View Drive
Newtown, PA, 18940
US

NAICS: 54Professional, Scientific, and Technical ServicesEdition: 2022
541Professional, Scientific, and Technical ServicesEdition: 2022
5417Scientific Research and Development ServicesEdition: 2022
54171Research and Development in the Physical, Engineering, and Life SciencesEdition: 2022
541714Research and Development in Biotechnology (except Nanobiotechnology)Edition: 2022
SIC: 87Engineering, Accounting, Research, Management, And Related ServicesEdition: 1987
873Research, Development, And Testing ServicesEdition: 1987
8731Commercial Physical and Biological ResearchEdition: 1987
Industry: Biotechnology Companies
Medical Organizations
Pharmaceutical Companies
Health Care Companies

Show 13 more industry codes

NAICS: 320000ManufacturingEdition: 2022
325Chemical ManufacturingEdition: 2022
3254Pharmaceutical and Medicine ManufacturingEdition: 2022
32541Pharmaceutical and Medicine ManufacturingEdition: 2022
325412Pharmaceutical Preparation Manufacturing

Edition: 2022

62Health Care and Social AssistanceEdition: 2022

623Nursing and Residential Care FacilitiesEdition: 2022

SIC

28Chemicals And Allied ProductsEdition: 1987
283DrugsEdition: 1987
2834Pharmaceutical PreparationsEdition: 1987
80Health ServicesEdition: 1987
804Offices And Clinics Of Other Health PractitionersEdition: 1987
8049Offices And Clinics Of Health Practitioners, Not Elsewhere ClassifiedEdition: 1987